Borja-Tabora, C. F. C., Peyrani, P., Webber, C., Van der Wielen, M., Cheuvart, B., De Schrevel, N., . . . Perez, J. L. (2020). A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years. BMC Infect Dis.
Styl cytowania ChicagoBorja-Tabora, Charissa Fay Corazon, et al. "A Phase 2b/3b MenACWY-TT Study of Long-term Antibody Persistence After Primary Vaccination and Immunogenicity and Safety of a Booster Dose in Individuals Aged 11 Through 55 years." BMC Infect Dis 2020.
Styl cytowania MLABorja-Tabora, Charissa Fay Corazon, et al. "A Phase 2b/3b MenACWY-TT Study of Long-term Antibody Persistence After Primary Vaccination and Immunogenicity and Safety of a Booster Dose in Individuals Aged 11 Through 55 years." BMC Infect Dis 2020.